Evidence map›Paper›PMID 42221406›Full record

ArticleAACE endocrinology and diabetes

Water-Clear Cell Parathyroid Adenoma Causing Delayed Diagnosis and Negative Imaging in Primary Hyperparathyroidism.

Marimar Hernandez Hernandez, Alex Gonzalez Bossolo, Zahira Lugo Lopez, Michelle Mangual Garcia, Ernesto Sola Sanchez, Miosotis Garcia Maldonado

Abstract readCase Reports
In one paragraph

Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marimar Hernandez HernandezSan Juan City Hospital Endocrinology Fellowship Program, San Juan, Puerto Rico.
Alex Gonzalez BossoloSan Juan City Hospital Endocrinology Fellowship Program, San Juan, Puerto Rico.
Zahira Lugo LopezSan Juan City Hospital Endocrinology Fellowship Program, San Juan, Puerto Rico.
Michelle Mangual GarciaSan Juan City Hospital Endocrinology Fellowship Program, San Juan, Puerto Rico.
Ernesto Sola SanchezSan Juan City Hospital Endocrinology Fellowship Program, San Juan, Puerto Rico.
Miosotis Garcia MaldonadoHRP Labs Pathology and Laboratory Medicine Department, San Juan, Puerto Rico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parathyroid water-clear cell adenomas are rare causes of primary hyperparathyroidism, with fewer than 30 cases reported in the medical literature worldwide. Over the years, these tumors have been associated with delayed diagnosis and treatment, as well as challenges in the management of hyperparathyroidism. We report the case of a 36-year-old female with a medical history of stage IV chronic kidney disease who presented with a large parathyroid adenoma composed predominantly of clear cells. Her diagnosis was delayed due to negative preoperative imaging findings despite markedly elevated parathyroid hormone levels of 1,100 pg/mL (reference range: 10-65 pg/mL) and serum calcium of 10.9 mg/dL (reference range: 8.0-10.5 mg/dL) while on cinacalcet therapy. A sestamibi parathyroid scan with SPECT/CT failed to localize the adenoma. However, given that the patient met multiple criteria for surgery-including young age, distal forearm osteoporosis, and a creatinine clearance below 60 mL/min-she was referred for parathyroidectomy. Intraoperatively, a large parathyroid adenoma was identified, which had not been detected on preoperative imaging. Histopathologic examination revealed a predominance of clear cells with fewer than 10% oxyphil cells and fewer than 5% chief cells, consistent with the water-clear cell subtype of parathyroid adenoma. Sestamibi imaging depends on delayed radiotracer washout from mitochondria-rich oxyphil cells; therefore, the high false-negative rate for this subtype may be attributed to its glycogen-rich, mitochondria-poor cytoplasm, which allows rapid tracer washout. Recognizing these tumors is crucial for the early diagnosis and appropriate management of primary hyperparathyroidism.

Indexed as

chronic kidney diseasehypercalcemiaparathyroid scanprimary hyperparathyroidismsestamibiwater-clear cell parathyroid adenoma

Identifiers

PMID42221406
PMCPMC13221922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.